TOP > 外国特許検索 > Method for screening of therapeutic agent for hyperlipemia

Method for screening of therapeutic agent for hyperlipemia NEW

外国特許コード F170009204
整理番号 A261-11WO
掲載日 2017年9月12日
出願国 欧州特許庁(EPO)
出願番号 10833235
公報番号 2505660
公報番号 2505660
出願日 平成22年11月25日(2010.11.25)
公報発行日 平成24年10月3日(2012.10.3)
公報発行日 平成26年5月21日(2014.5.21)
国際出願番号 JP2010070959
国際公開番号 WO2011065389
国際出願日 平成22年11月25日(2010.11.25)
国際公開日 平成23年6月3日(2011.6.3)
優先権データ
  • 特願2009-269593 (2009.11.27) JP
  • 2010WO-JP70959 (2010.11.25) WO
発明の名称 (英語) Method for screening of therapeutic agent for hyperlipemia NEW
発明の概要(英語) (EP2505660)
Disclosed are a highly safe treatment method for hyperlipidemia and a therapeutic agent for hyperlipidemia.
Specifically, the invention provides a novel method for screening an agent for treating hyperlipidemia, more specifically, a method for screening a substance that can inhibit the production or function of gangliosides, particularly GM3, or inhibit the activity or expression of GM3 synthase to reduce a blood lipid level.
A pharmaceutical composition, which can specifically inhibit the production of gangliosides, particularly GM3, thereby effective for hyperlipidemia treatment, and others are also provided.
特許請求の範囲(英語) [claim1]
1. A method for screening a substance having a blood lipid level lowering activity, which comprises: (i) contacting GM3 synthase with a substrate thereof in the presence or absence of a test substance, (ii) selecting a test substance that decreases the synthesized amount of GM3, (iii) administering the selected test substance to a non-human animal, and (iv) determining the blood lipid level in the non-human animal.
[claim2]
2. A method for screening a substance having a blood lipid level lowering activity, which comprises: (i) contacting a test substance with a cell expressing GM3 synthase, (ii) selecting a test substance that decreases the expression level of GM3 synthase, (iii) administering the selected test substance to a non-human animal, and (iv) determining the blood lipid level in the non-human animal.
[claim3]
3. The method according to claim 2, wherein the cell expressing GM3 synthase is selected from the group consisting of adipocytes, hepatocytes, vascular endothelial cells, vascular smooth muscle cells, skeletal muscle cells, epithelial cells, neurocytes, fibroblasts, monocytes and macrophages.
[claim4]
4. The method according to claim 2, wherein the cell expressing GM3 synthase is a transformant produced by genetic engineering.
[claim5]
5. The screening method according to any one of claims 1 to 4, which further comprises selecting a test substance that reduces a blood cholesterol level and/or a blood triglyceride level.
[claim6]
6. The method according to any one of claims 1 to 5, wherein the non-human animal has a higher blood lipid level than normal level.
[claim7]
7. The method according to any one of claims 1 to 6, wherein the non-human animal is a mouse.
[claim8]
8. A pharmaceutical composition effective for treatment of hyperlipidemia, comprising a substance that specifically prevents a production of a ganglioside.
[claim9]
9. The composition according to claim 8, wherein the ganglioside is GM3.
[claim10]
10. A pharmaceutical composition effective for treatment of hyperlipidemia, comprising an antibody against GM3, a GM3 synthase inhibitor, or a substance that inhibits GM3 synthase expression.
  • 出願人(英語)
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
  • 発明者(英語)
  • INOKUCHI JINICHI
  • NAGAFUKU MASAKAZU
  • HAYAMIZU HIROTAKA
国際特許分類(IPC)
欧州特許分類/主・副
  • A61K045/06
  • C12Q001/48
  • C12Q001/60
  • C12Q001/61
  • S01N333/910D9
  • S01N405/10
  • S01N500/02
  • S01N800/04B
  • S01N800/32D
指定国 (EP2505660)
Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
参考情報 (研究プロジェクト等) CREST Clarification of the Biological Functions of Sugar Chains and the Use of this Knowledge in Applied Technologies AREA
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close